Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1437
https://www.valueinhealthjournal.com/article/S1098-3015(17)31771-0/fulltext
Title :
Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31771-0&doi=10.1016/j.jval.2017.08.1437
First page :
A634
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1280